SMTL ID : 3l3n.1

Testis ACE co-crystal structure with novel inhibitor lisW

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.30 Å

Oligo State

monomer

Ligands

1 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-FUC.1: 5 residues within 4Å: Chain A: S.9, E.13, N.73, T.75, I.76 1 PLIP interactions: 1 interactions with chain A Hydrophobic interactions: A:I.76, A:T.75 Hydrogen bonds: A:E.13

1 x ZN: ZINC ION(Non-covalent)

ZN.2: 4 residues within 4Å: Chain A: H.347, H.351, E.375 Ligands: LSW.5 4 PLIP interactions: 3 interactions with chain A, 1 Ligand-Ligand interactions Metal complexes: A:H.347, A:H.351, A:E.375, LSW.5

2 x CL: CHLORIDE ION(Non-functional Binders)

CL.3: 5 residues within 4Å: Chain A: R.150, W.449, W.450, R.453, D.471 Ligand excluded by PLIP CL.4: 6 residues within 4Å: Chain A: M.187, Y.188, P.371, P.483, I.485, R.486 Ligand excluded by PLIP

1 x LSW: N~2~-[(1S)-1-carboxy-3-phenylpropyl]-L-lysyl-L-tryptophan(Non-covalent)

LSW.5: 21 residues within 4Å: Chain A: E.126, Q.245, H.317, A.318, S.319, D.341, V.344, H.347, E.348, H.351, E.375, D.379, F.421, K.475, F.476, H.477, V.482, Y.484, Y.487, F.491 Ligands: ZN.2 18 PLIP interactions: 18 interactions with chain A Hydrophobic interactions: A:A.318, A:V.344, A:V.344, A:F.421, A:F.476, A:V.482, A:Y.487 Hydrogen bonds: A:E.126, A:Q.245, A:H.317, A:A.318, A:D.379 Water bridges: A:A.318 Salt bridges: A:H.317, A:H.347, A:H.351, A:K.475, A:H.477

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Watermeyer, J.M. et al., Characterization of domain-selective inhibitor binding in angiotensin-converting enzyme using a novel derivative of lisinopril. Biochem.J. (2010)

Release Date

2010-04-28

Peptides

Angiotensin-converting enzyme: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Angiotensin-converting enzyme

Related Entries With Identical Sequence